We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
-0.25%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$219M
AUM Growth
-$6.3M
(-2.8%)
Cap. Flow
+$7.95M
Cap. Flow
% of AUM
3.64%
Top 10 Holdings %
Top 10 Hldgs %
11.93%
Holding
763
New
327
Increased
77
Reduced
54
Closed
297
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$2.61M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.35M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$2.15M |
| 4 |
Teck Resources
TECK
|
+$2.12M |
| 5 |
BlackRock Health Sciences Trust II
BMEZ
|
+$2.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$3.72M |
| 2 |
Cintas
CTAS
|
+$3.03M |
| 3 |
BCOV
Brightcove, Inc.
BCOV
|
+$2.87M |
| 4 |
Verizon
VZ
|
+$2.3M |
| 5 |
Veeva Systems
VEEV
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.88% |
| 2 | Financials | 13.01% |
| 3 | Technology | 12.25% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Industrials | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Neurocrine Biosciences
NBIX
$16.6B
| $337K | 0.15% |
+3,051
| New | +$387K |
|
227
Arch Capital
ACGL
$33.4B
| $337K | 0.15% |
+3,508
| New | +$324K |
|
228
Agilent Technologies
A
$41.8B
| $337K | 0.15% |
+2,881
| New | +$388K |
|
|
SWTX
229
DELISTED
SpringWorks Therapeutics
SWTX
| $337K | 0.15% |
+7,631
| New | +$351K |
|
230
XPO
XPO
$23.5B
| $336K | 0.15% |
+3,119
| New | +$396K |
|
231
Arcutis Biotherapeutics
ARQT
$3.21B
| $334K | 0.15% |
+21,324
| New | +$300K |
|
232
Ross Stores
ROST
$81.8B
| $331K | 0.15% |
+2,591
| New | +$363K |
|
233
Atlassian
TEAM
$37.3B
| $331K | 0.15% |
1,559
+559
| +56% | +$148K |
|
234
Philip Morris
PM
$291B
| $330K | 0.15% |
2,078
-1,650
| -44% | -$234K |
|
|
EXAS
235
DELISTED
Exact Sciences
EXAS
| $329K | 0.15% |
+7,604
| New | +$385K |
|
|
VTLE
236
DELISTED
Vital Energy
VTLE
| $328K | 0.15% |
+15,468
| New | +$448K |
|
|
LNW
237
DELISTED
Light & Wonder
LNW
| $326K | 0.15% |
+3,762
| New | +$362K |
|
238
Otter Tail
OTTR
$3.91B
| $325K | 0.15% |
+4,040
| New | +$320K |
|
239
Prudential Financial
PRU
$41.8B
| $321K | 0.15% |
+2,877
| New | +$328K |
|
240
Dow Inc
DOW
$21.6B
| $320K | 0.15% |
9,150
-18,423
| -67% | -$707K |
|
|
THS
241
DELISTED
Treehouse Foods
THS
| $319K | 0.15% |
+11,785
| New | +$374K |
|
242
Globant
GLOB
$1.61B
| $317K | 0.15% |
+2,697
| New | +$484K |
|
243
Roku
ROKU
$22.6B
| $316K | 0.14% |
+4,490
| New | +$359K |
|
244
Best Buy
BBY
$17.2B
| $314K | 0.14% |
4,265
-963
| -18% | -$79.4K |
|
245
Emergent Biosolutions
EBS
$232M
| $313K | 0.14% |
+64,377
| New | +$533K |
|
246
Upwork
UPWK
$1.19B
| $313K | 0.14% |
+23,972
| New | +$365K |
|
247
Fortrea Holdings
FTRE
$1.79B
| $313K | 0.14% |
+41,416
| New | +$585K |
|
248
Iridium Communications
IRDM
$5.22B
| $310K | 0.14% |
+11,356
| New | +$333K |
|
249
Oil States International
OIS
$525M
| $309K | 0.14% |
60,060
+49,666
| +478% | +$261K |
|
|
GAP
250
The Gap Inc
GAP
$7.6B
| $308K | 0.14% |
+14,945
| New | +$336K |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Oxford Asset Management held 763 positions worth $219M, down 2.8% from $225M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Oxford Asset Management deployed $7.95M of net new capital in Q1 2025, opening 327 new positions and adding to 77 existing holdings. Its largest new stake was Oracle: 16,001 shares worth $2.24M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Cintas, an estimated $3.03M trimmed.
- Oxford Asset Management's largest Q1 2025 buy was Oracle: 16,001 shares worth $2.24M.
- Oxford Asset Management added most to NEVRO CORP. in Q1 2025, an estimated $2.05M increase.
- Oxford Asset Management's biggest Q1 2025 reduction was Cintas, cutting an estimated $3.03M.
- Oxford Asset Management fully exited Avid Bioservices, Inc. Common Stock in Q1 2025, selling an estimated $3.72M.
- Oxford Asset Management's ten largest holdings make up 12% of its $219M portfolio in Q1 2025.
- Oxford Asset Management opened 327 new positions and closed 297 in Q1 2025.
- Oxford Asset Management's portfolio value fell 2.8% quarter-over-quarter to $219M.
Based on Oxford Asset Management's 13F filing for Q1 2025, filed 15 May 2025.